EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) SVP Sells $22,500 00 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) SVP David Scott Jones sold 600 shares of the business’s stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $25.00, for a total value of $15,000.00. Following the completion of the sale, the senior vice president now […]
JPMorgan Chase & Co. began coverage on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) in a research note published on Monday morning, Marketbeat.com reports. The firm issued an overweight rating and a $35.00 target price on the stock. A number of other research analysts have also recently issued reports on the company. Capital One […]
Dario Paggiarino, Chief Medical Officer of EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), sold 16,386 shares of the company on January 24, 2024, according to a recent SEC Filing.